We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.3B
AUM Growth
+$7.71M
Cap. Flow
+$92.4M
Cap. Flow %
7.09%
Top 10 Hldgs %
6.04%
Holding
1,409
New
392
Increased
321
Reduced
279
Closed
417

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$9.84M
2
LH icon
Labcorp
LH
+$8.89M
3
HUBB icon
Hubbell
HUBB
+$7.76M
4
SNY icon
Sanofi
SNY
+$7.7M
5
JHG
Janus Henderson
JHG
+$7.68M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$10.4M
2
FAST icon
Fastenal
FAST
+$10.2M
3
HCA icon
HCA Healthcare
HCA
+$9.44M
4
SCHW
Charles Schwab
SCHW
+$9.09M
5
NVS icon
Novartis
NVS
+$9.01M

Sector Composition

Rank Sector Weight
1 Financials 17%
2 Healthcare 16.16%
3 Consumer Discretionary 11.61%
4 Industrials 11.13%
5 Technology 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TROW icon
51
T. Rowe Price
TROW
$24.3B
$4.27M 0.33%
46,523
+32,687
+236% +$3.45M
TSN icon
52
Tyson Foods
TSN
$19.9B
$4.27M 0.33%
+66,959
New +$3.93M
PB icon
53
Prosperity Bancshares
PB
$8.85B
$4.27M 0.33%
59,837
+28,567
+91% +$2.16M
AZN icon
54
AstraZeneca
AZN
$246B
$4.25M 0.33%
28,884
+20,756
+255% +$3M
RGLD icon
55
Royal Gold
RGLD
$19.8B
$4.21M 0.32%
+25,751
New +$3.78M
PEP icon
56
PepsiCo
PEP
$189B
$4.19M 0.32%
27,922
+21,012
+304% +$3.13M
BNS icon
57
Scotiabank
BNS
$108B
$4.18M 0.32%
+88,225
New +$4.43M
WH icon
58
Wyndham Hotels & Resorts
WH
$5.38B
$4.17M 0.32%
+46,070
New +$4.67M
PRGO icon
59
Perrigo
PRGO
$1.78B
$4.13M 0.32%
147,384
+120,623
+451% +$3.13M
LNT icon
60
Alliant Energy
LNT
$17.8B
$4.12M 0.32%
+64,059
New +$3.92M
ASH icon
61
Ashland
ASH
$3.42B
$4.11M 0.32%
69,270
+36,200
+109% +$2.31M
UNH icon
62
UnitedHealth
UNH
$365B
$4.07M 0.31%
+7,774
New +$3.97M
GWW icon
63
W.W. Grainger
GWW
$61.3B
$4.02M 0.31%
4,069
-3,634
-47% -$3.76M
DAL icon
64
Delta Air Lines
DAL
$59.5B
$4.02M 0.31%
92,168
-5,700
-6% -$338K
CNC icon
65
Centene
CNC
$32.1B
$3.9M 0.3%
+64,254
New +$3.88M
DECK icon
66
Deckers Outdoor
DECK
$12.8B
$3.88M 0.3%
34,680
+29,244
+538% +$4.72M
ILMN icon
67
Illumina
ILMN
$29.1B
$3.82M 0.29%
+48,199
New +$5.22M
CFR icon
68
Cullen/Frost Bankers
CFR
$10.3B
$3.81M 0.29%
30,467
+23,947
+367% +$3.22M
EVR icon
69
Evercore
EVR
$11.7B
$3.68M 0.28%
18,435
+12,826
+229% +$3.2M
JAZZ icon
70
Jazz Pharmaceuticals
JAZZ
$16.1B
$3.67M 0.28%
+29,592
New +$3.86M
WRB icon
71
W.R. Berkley
WRB
$26B
$3.66M 0.28%
51,453
+28,434
+124% +$1.74M
PYPL icon
72
PayPal
PYPL
$50.5B
$3.65M 0.28%
+55,981
New +$4.36M
FITB
73
Fifth Third Bancorp
FITB
$52.2B
$3.63M 0.28%
92,615
-4,356
-4% -$184K
EXC icon
74
Exelon
EXC
$46.2B
$3.62M 0.28%
+78,606
New +$3.29M
SNDR icon
75
Schneider National
SNDR
$6.12B
$3.62M 0.28%
+158,292
New +$4.29M
1 2
3
4 5

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return

Campbell & Co Investment Adviser's Q1 2025 Portfolio in Review

As of Q1 2025, Campbell & Co Investment Adviser held 1,409 positions worth $1.3B, up 0.6% from $1.3B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Campbell & Co Investment Adviser deployed $92.4M of net new capital in Q1 2025, opening 392 new positions and adding to 321 existing holdings. Its largest new stake was Synchrony: 159,080 shares worth $8.42M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $9.01M trimmed.

  • Campbell & Co Investment Adviser's largest Q1 2025 buy was Synchrony: 159,080 shares worth $8.42M.
  • Campbell & Co Investment Adviser added most to Labcorp in Q1 2025, an estimated $8.89M increase.
  • Campbell & Co Investment Adviser's biggest Q1 2025 reduction was Novartis, cutting an estimated $9.01M.
  • Campbell & Co Investment Adviser fully exited Intercontinental Exchange in Q1 2025, selling an estimated $10.4M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.3B portfolio in Q1 2025.
  • Campbell & Co Investment Adviser opened 392 new positions and closed 417 in Q1 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 0.6% quarter-over-quarter to $1.3B.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.